TFII-I regulates induction of chromosomally integrated human immunodeficiency virus type 1 long terminal repeat in cooperation with USF

Journal of Virology

Volumn 79, Issue 7, 2005, Pages 4396-4406

  Chen, Jiguo ^a   Malcolm, Tom ^a   Estable, Mario C ^b,c   Roeder, Robert G ^c   Sadowski, Ivan ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b RYERSON UNIVERSITY   (Canada)

^c ROCKEFELLER UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; CHICKEN OVALBUMIN UPSTREAM PROMOTER TRANSCRIPTION FACTOR; CIS ACTING ELEMENT; I KAPPA B ALPHA; IONOMYCIN; PHORBOL 13 ACETATE 12 MYRISTATE; PROTEIN RBEIII; RAS RESPONSE ELEMENT BINDING FACTOR 2; RECOMBINANT PROTEIN; T LYMPHOCYTE RECEPTOR; UNCLASSIFIED DRUG; UPSTREAM STIMULATORY FACTOR 1; UPSTREAM STIMULATORY FACTOR 2;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANIMAL CELL; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; CROSS LINKING; E BOX ELEMENT; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; LEUKEMIA CELL LINE; LONG TERMINAL REPEAT; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; T LYMPHOCYTE ACTIVATION; TRANSCRIPTION INITIATION; VIRUS DNA CELL DNA INTERACTION; VIRUS MUTATION; VIRUS REPLICATION;

ANIMALS; COS CELLS; DIMERIZATION; DNA-BINDING PROTEINS; ELECTROPHORETIC MOBILITY SHIFT ASSAY; GENE EXPRESSION REGULATION, VIRAL; HIV LONG TERMINAL REPEAT; HIV-1; HUMANS; JURKAT CELLS; LYMPHOCYTE ACTIVATION; PHOSPHORYLATION; PROTEIN BINDING; RECEPTORS, ANTIGEN, T-CELL; T-LYMPHOCYTES; TRANSCRIPTION FACTORS; TRANSCRIPTION FACTORS, TFII; TRANSCRIPTION, GENETIC; UPSTREAM STIMULATORY FACTORS; VIRUS ACTIVATION; VIRUS INTEGRATION; VIRUS REPLICATION;

EID: 15244346525     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.79.7.4396-4406.2005     Document Type: Article

References (50)

1. Archer, T. K., E. Zaniewski, M. L. Moyer, and S. K. Nordeen. 1994. The differential capacity of glucocorticoids and progestins to alter chromatin structure and induce gene expression in human breast cancer cells. Mol. Endocrinol. 8:1154-1162.
2. Bell, B., and I. Sadowski. 1996. Ras-responsiveness of the HIV-1 LTR requires RBF-1 and RBF-2 binding sites. Oncogene 13:2687-2697.
3. Bell, B., E. Scheer, and L. Tora. 2001. Identification of hTAF(II)80 delta links apoptotic signaling pathways to transcription factor TFIID function. Mol. Cell 8:591-600.
4. Bird, T. A., K. Schooley, S. K. Dower, H. Hagen, and G. D. Virca. 1997. Activation of nuclear transcription factor NF-kappaB by interleukin-1 is accompanied by casein kinase II-mediated phosphorylation of the p65 subunit. J. Biol. Chem. 272:32606-32612.
5. Bruno, M. E., R. B. West, T. A. Schneeman, E. H. Bresnick, and C. S. Kaetzel. 2004. Upstream stimulatory factor but not c-Myc enhances transcription of the human polymeric immunoglobulin receptor gene. Mol. Immunol. 40:695-708.
6. Cheriyath, V., Z. P. Desgranges, and A. L. Roy. 2002. c-Src-dependent transcriptional activation of TFII-I. J. Biol. Chem. 277:22798-22805.
7. Cheriyath, V., C. D. Novina, and A. L. Roy. 1998. TFII-I regulates Vbeta promoter activity through an initiator element. Mol. Cell. Biol. 18:4444-4454.
8. Cheung, E., P. Mayr, F. Coda-Zabetta, P. G. Woodman, and D. S. Boam. 1999. DNA-binding activity of the transcription factor upstream stimulatory factor 1 (USF-1) is regulated by cyclin-dependent phosphorylation. Biochem. J. 344:145-152.
9. Coffin, J. M. 1995. HIV population dynamics in vivo: implications for genetic variation, pathogenesis and therapy. Science 267:483-489.
10. Coulson, J. M., J. L. Edgson, Z. V. Marshall-Jones, R. Mulgrew, J. P. Quinn, and P. J. Woll. 2003. Upstream stimulatory factor activates the vasopressin promoter via multiple motifs, including a non-canonical E-box. Biochem. J. 369:549-561.
11. Du, H., A. L. Roy, and R. G. Roeder. 1993. Human transcription factor USF stimulates transcription through the initiator elements of the HIV-1 and the Ad-ML promoters. EMBO J. 12:501-511.
12. Estable, M. C., B. Bell, M. Hirst, and I. Sadowski. 1998. Naturally occurring human immunodeficiency virus type 1 long terminal repeats have a frequently observed duplication that binds RBF-2 and represses transcription. J. Virol. 72:6465-6474.
13. Estable, M. C., B. Bell, A. Merzouki, J. S. Montaner, M. V. O'Shaughnessy, and I. J. Sadowski. 1996. Human immunodeficiency virus type 1 long terminal repeat variants from 42 patients representing all stages of infection display a wide range of sequence polymorphism and transcription activity. J. Virol. 70:4053-4062.
14. Estable, M. C., M. Hirst, B. Bell, M. V. O'Shaughnessy, and I. Sadowski. 1999. Purification of RBF-2, a transcription factor with specificity for the most conserved cis-element of naturally occurring HIV-1 LTRs. J. Biomed. Sci. 6:320-332.
15. Galibert, M. D., S. Carreira, and C. R. Coding. 2001. The Usf-1 transcription factor is a novel target for the stress-responsive p38 kinase and mediates UV-induced tyrosinase expression. EMBO J. 20:5022-5031.
16. Griffin, G. E., K. Leung, T. M. Folks, S. Kunkel, and G. J. Nabel. 1989. Activation of HIV gene expression during monocyte differentiation by induction of NF-κB. Nature 339:70-73.
17. Harris, V. K., C. M. Coticchia, H. J. List, A. Wellstein, and A. T. Riegel. 2000. Mitogen-induced expression of the fibroblast growth factor-binding protein is transcriptionally repressed through a non-canonical E-box element. J. Biol. Chem. 275:28539-28548.
18. Huang, Y., and R. L. Wange. 2004. T cell receptor signaling: beyond complex complexes. J. Biol. Chem. 279:28827-28830.
19. Jeeninga, R. E., M. Hoogenkamp, M. Armand-Ugon, M. de Baar, K. Verhoef, and B. Berkhout. 2000. Functional differences between the long terminal repeat transcriptional promoters of human immunodeficiency virus type 1 subtypes A through G. J. Virol. 74:3740-3751.
20. Kim, D. W., and B. H. Cochran. 2000. Extracellular signal-regulated kinase binds to TFII-I and regulates its activation of the c-fos promoter. Mol. Cell. Biol. 20:1140-1148.
21. Kim, D. W., and B. H. Cochran. 2001. JAK2 activates TFII-I and regulates its interaction with extracellular signal-regulated kinase. Mol. Cell. Biol. 21:3387-3397.
22. Koken, S. E., J. L. van Wamel, J. Goudsmit, B. Berkhout, and J. L. Geelen. 1992. Natural variants of the HIV-1 long terminal repeat: analysis of promoters with duplicated DNA regulatory motifs. Virology 191:968-972.
23. Kwon, H., N. Pelletier, C. DeLuca, P. Genin, S. Cisternas, R. Lin, M. A. Wainberg, and J. Hiscott. 1998. Inducible expression of IkappaBalpha repressor mutants interferes with NF-kappaB activity and HIV-1 replication in Jurkat T cells. J. Biol. Chem. 273:7431-7440.
24. Luo, X., and M. Sawadogo. 1996. Functional domains of the transcription factor USF2: atypical nuclear localization signals and context-dependent transcriptional activation domains. Mol. Cell. Biol. 16:1367-1375.
25. Lusic, M., A. Marcello, A. Cereseto, and M. Giacca. 2003. Regulation of HIV-1 gene expression by histone acetylation and factor recruitment at the LTR promoter. EMBO J. 22:6550-6561.
26. Michael, N. L., L. D'Arcy, P. K. Ehrenberg, and R. R. Redfield. 1994. Naturally occurring genotypes of the human immunodeficiency virus type 1 long terminal repeat display a wide range of basal and Tat-induced transcriptional activities. J. Virol. 68:3163-3174.
27. Nabel, G., and D. Baltimore. 1987. An inducible transcription factor activates expression of human immunodeficiency virus in T cells. Nature 326: 711-713.
28. Naghavi, M. H., M. C. Estable, S. Schwartz, R. G. Roeder, and A. Vahlne. 2001. Upstream stimulating factor affects human immunodeficiency virus type 1 (HIV-1) long terminal repeat-directed transcription in a cell-specific manner, independently of the HIV-1 subtype and the core-negative regulatory element. J. Gen. Virol. 82:547-559.
29. Ozes, O. N., L. D. Mayo, J. A. Gustin, S. R. Pfeffer, L. M. Pfeffer, and D. B. Donner. 1999. NF-kappaB activation by tumour necrosis factor requires the Akt serine-threonine kinase. Nature 401:82-85.
30. Pereira, L. A., K. Bentley, A. Peeters, M. J. Churchill, and N. J. Deacon. 2000. A compilation of cellular transcription factor interactions with the HIV-1 LTR promoter. Nucleic Acids Res. 28:663-668.
31. Persaud, D., Y. Zhou, J. M. Siliciano, and R. F. Siliciano. 2003. Latency in human immunodeficiency virus type 1 infection: no easy answers. J. Virol. 77:1659-1665.
32. Ptashne, M. 2003. Regulated recruitment and cooperativity in the design of biological regulatory systems. Philos. Trans. Ser. A 361:1223-1234.
33. Qyang, Y., X. Luo, T. Lu, P. M. Ismail, D. Krylov, C. Vinson, and M. Sawadogo. 1999. Cell-type-dependent activity of the ubiquitous transcription factor USF in cellular proliferation and transcriptional activation. Mol. Cell. Biol. 19:1508-1517.
34. Ribeiro, A., D. Pastier, D. Kardassis, J. Chambaz, and P. Cardot. 1999. Cooperative binding of upstream stimulatory factor and hepatic nuclear factor 4 drives the transcription of the human apolipoprotein A-II gene. J. Biol. Chem. 274:1216-1225.
35. Roy, A. L. 2001. Biochemistry and biology of the inducible multifunctional transcription factor TFII-I. Gene 274:1-13.
36. Roy, A. L., H. Du, P. D. Gregor, C. D. Novina, E. Martinez, and R. G. Roeder. 1997. Cloning of an inr- and E-box-binding protein, TFII-I, that interacts physically and functionally with USF1. EMBO J. 16:7091-7104.
37. Roy, A. L., M. Meisterernst, P. Pognonec, and R. G. Roeder. 1991. Cooperative interaction of an initiator-binding transcription initiation factor and the helix-loop-helix activator USF. Nature 354:245-248.
38. Sacristan, C., M. I. Tussie-Luna, S. M. Logan, and A. L. Roy. 2004. Mechanism of Bruton's tyrosine kinase-mediated recruitment and regulation of TFII-I. J. Biol. Chem. 279:7147-7158.
39. Sadowski, I., J. C. Stone, and T. Pawson. 1986. A noncatalytic domain conserved among cytoplasmic protein-tyrosine kinases modifies the kinase function and transforming activity of Fujinami sarcoma virus P130gag-fps. Mol. Cell. Biol. 6:4396-4408.
40. Sieweke, M. H., H. Tekotte, U. Jarosch, and T. Graf. 1998. Cooperative interaction of ets-1 with USF-1 required for HIV-1 enhancer activity in T cells. EMBO J. 17:1728-1739.
41. Sigala, J. L., V. Bottero, D. B. Young, A. Shevchenko, F. Mercurio, and I. M. Verma. 2004. Activation of transcription factor NF-kappaB requires ELKS, an IkappaB kinase regulatory subunit. Science 304:1963-1967.
42. Sirito, M., Q. Lin, J. M. Deng, R. R. Behringer, and M. Sawadogo. 1998. Overlapping roles and asymmetrical cross-regulation of the USF proteins in mice. Proc. Natl. Acad. Sci. USA 95:3758-3763.
43. Sirito, M., Q. Lin, T. Maity, and M. Sawadogo. 1994. Ubiquitous expression of the 43- and 44-kDa forms of transcription factor USF in mammalian cells. Nucleic Acids Res. 22:427-433.
44. Takahashi, K., C. Nishiyama, M. Nishiyama, K. Okumura, C. Ra, Y. Ohtake, and T. Yokota. 2001. A complex composed of USF1 and USF2 activates the human FcepsilonRI alpha chain expression via a CAGCTG element in the first intron. Eur. J. Immunol. 31:590-599.
45. Timchenko, N., D. R. Wilson, L. R. Taylor, S. Abdelsayed, M. Wilde, M. Sawadogo, and G. J. Darlington. 1995. Autoregulation of the human C/EBP alpha gene by stimulation of upstream stimulatory factor binding. Mol. Cell. Biol. 15:1192-1202.
46. Van Antwerp, D. J., S. J. Martin, T. Kafri, D. R. Green, and I. M. Verma. 1996. Suppression of TNF-alpha-induced apoptosis by NF-kappaB. Science 274:787-789.
47. Virolle, T., C. Coraux, O. Ferrigno, L. Cailleteau, J. P. Ortonne, P. Pognonec, and D. Aberdam. 2002. Binding of USF to a non-canonical E-box following stress results in a cell-specific derepression of the lama3 gene. Nucleic Acids Res. 30:1789-1798.
48. Weiss, A., and J. D. Stobo. 1984. Requirement for the coexpression of T3 and the T cell antigen receptor on a malignant human T cell line. J. Exp. Med. 160:1284-1299.
49. Wen, Y. D., W. D. Cress, A. L. Roy, and E. Seto. 2003. Histone deacetylase 3 binds to and regulates the multifunctional transcription factor TFII-I. J. Biol. Chem. 278:1841-1847.
50. Zhang, L., Y. Huang, H. Yuan, B. K. Chen, J. Ip, and D. D. Ho. 1997. Identification of a replication-competent pathogenic human immunodeficiency virus type 1 with a duplication in the TCF-1alpha region but lacking NF-kappaB binding sites. J. Virol. 71:1651-1656.